Link Pharma Chem Limited (BOM:524748)
India flag India · Delayed Price · Currency is INR
27.50
+1.30 (4.96%)
At close: Aug 21, 2026

Link Pharma Chem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
283.85274.32254.33298.98387.58535.61
Revenue Growth
16.32%7.86%-14.93%-22.86%-27.64%53.85%
Gross Profit
161.3161.41125.37126.05165.83163.53
Operating Income
4.275.05-8.14-16.8417.9525.74
Net Income
-0.070.77-10.27-13.636.5418.82
Earnings Per Share
-0.020.17-2.31-3.071.474.24
EPS Growth
-----65.23%73.45%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
5.885.880.650.640.942.68
Total Debt
73.0473.0457.8292.2287.5763.88
Net Cash (Debt)
-67.17-67.17-57.18-91.58-86.63-61.2
Net Cash Growth
------
Net Cash Per Share
-15.12-15.13-12.88-20.62-19.51-13.78

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-21.4726.86-0.28-17.07-12.59
Capital Expenditures
--21-2.57-9.5-8.93-11.56
Free Cash Flow
-0.4724.29-9.78-26-24.15
Free Cash Flow Growth
--98.08%----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
56.83%58.84%49.29%42.16%42.79%30.53%
Operating Margin
1.50%1.84%-3.20%-5.63%4.63%4.81%
Pretax Margin
0.05%0.49%-5.51%-6.41%2.29%4.89%
Profit Margin
-0.02%0.28%-4.04%-4.56%1.69%3.51%
FCF Margin
-0.17%9.55%-3.27%-6.71%-4.51%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-130.85--24.859.50
P/FCF Ratio
262.05215.936.18---
PS Ratio
0.430.370.590.630.420.33